Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.20
-0.15 (-2.80%)
At close: Mar 6, 2026, 4:00 PM EST
5.30
+0.10 (1.92%)
After-hours: Mar 6, 2026, 7:47 PM EST
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $360.71 million as of March 6, 2026. Its market cap has decreased by -57.42% in one year.
Market Cap
360.71M
Enterprise Value
-281.87M
1-Year Change
-57.42%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $360.71M, an increase of 69.86%. That is a compound annual growth rate of 8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 371.12M | -24.44% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Absci | 389.46M |
| PepGen | 378.46M |
| LENZ Therapeutics | 377.36M |
| Crescent Biopharma | 376.31M |
| Aclaris Therapeutics | 376.26M |
| Monopar Therapeutics | 372.89M |
| Sutro Biopharma | 368.72M |
| Benitec Biopharma | 363.10M |